福泰製藥 VRTX 深 滬
等待開盤 08-01 09:30:00 美东时间
461.05
-8.110
-1.73%
華盛通- 最 高470.59
- 今 開465.29
- 成交量 73.47万股
- 最 低 460.07
- 昨 收 469.16
- 總市值 1184.90亿
- 52周最高 519.88
- 市盈率 靜 --
- 換手率 0.29%
- 52周最低 377.85
- 委 比 92.59%
- 總股本 2.57亿
- 歷史最高 519.88
- 量 比 0.71
- 振 幅 2.24%
- 歷史最低 26.50
- 每 手 1
- 風險率 42.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多特朗普“药品关税”对哪些制药商影响最大？一文看懂
①特朗普政府启动针对进口药品的国家安全调查，可能对药品行业征收高达200%的关税。②分析人士评估，艾伯维、百时美施贵宝和礼来等公司因在美国生产规模大而受影响较小，而诺华和罗氏风险更大。
07-30 11:43
Seeking value? 10 standout stocks according to SA metrics
With Wall Street trading at all-time highs, some investors are turning to value-oriented positions as a way to uncover overlooked opportunities and add a layer of stability amid elevated valuations. A...
07-29 23:58
Vornado Realty Trust Leases 203,000 SF to Verizon for New York Headquarters in THE PENN DISTRICT
Verizon will relocate its New York headquarters to PENN 2, Vornado's reimagined office tower in THE PENN DISTRICT, under a 19-year lease. The company will occupy nearly 200,000 sq.ft. across floors 8-10, with exclusive access to 25,000 sq.ft. of outdoor space, and establish a flagship retail location on Seventh Avenue. PENN 2 features modern design, outdoor green spaces, and advanced amenities, positioning THE PENN DISTRICT as a vibrant campus wi...
07-29 12:17
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
Roivant announced it will host a live conference call and webcast on August 11, 2025, at 8:00 a.m. ET, to discuss its Q1 2025 financial results and provide a business update. Registration for the call is available via a provided link, and webcast details will be accessible on its投资者 section. Roivant, a biopharmaceutical company, focuses on accelerating medicine development and commercialization, with a pipeline including IMVT-1402, batoclimab, br...
07-28 20:05
VirTra Sets Second Quarter 2025 Conference Call for Monday, August 11, 2025 at 4:30 p.m. ET
VirTra, Inc. (Nasdaq: VTSI) will hold a conference call on August 11, 2025, at 4:30 p.m. ET (1:30 p.m. PT) to discuss its second-quarter 2025 financial results. The call will include a presentation by VirTra management followed by a Q&A session. Details for dial-in numbers, conference ID, and live webcast are provided. A replay will be available starting at 7:30 p.m. ET on the same day through August 25, 2025. VirTra offers judgmental use-of-forc...
07-28 20:05
New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox
Emergent BioSolutions Inc. has published a review article on brincidofovir's potential in treating mpox, highlighting its antiviral properties, clinical trial progress in Africa, and combination therapy possibilities.Mpox, declared a global health emergency, remains a significant threat, driving the need for effective treatments.
07-28 12:50
Vertex Report: U.S. Sees Continued Acceleration in Sales Tax Rates and Rules Changes
Vertex's 2025 Mid-Year Report reveals 408 U.S. sales tax rate changes, a 24% increase from 2024. Local jurisdictions drive most updates, with Louisiana raising its state rate. Cities and districts face compliance complexity amid inflation and shrinking spending. New taxing areas have surged, making compliance challenging. The rise in digital taxation and evolving global trade dynamics highlight the need for adaptive tax strategies.
07-28 12:00
干细胞走向临床：癌症、糖尿病和帕金森病的治疗方法或将问世 | 红杉爱科学
近年来，干细胞逐渐从实验室走向临床，在多个领域展现出潜力，为治疗多种疑难杂症提供了全新思路。 一篇发表于《自然》的专题文章中，以帕金森病患者Andrew C...
07-24 08:02
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
Invivyd, Inc. has announced the addition of Dr. Akiko Iwasaki to the SPEAR Study Group, focusing on the biology and clinical effects of the persistent SARS-CoV-2 spike antigen. Her expertise in viral pathogenesis and post-viral chronic conditions, including Long COVID and PVS, will guide the group's efforts to explore the safety and efficacy of monoclonal antibodies in treating these conditions. The SPEAR Study Group is planning clinical trials u...
07-23 11:01
Vornado Announces Second Quarter Earnings Release Date and Conference Call Information
Vornado Realty Trust announced its pending filing of the Q2 10-Q report with the SEC on August 4, 2025, after the NYSE close. A conference call and webcast will follow on August 5 at 10:00 a.m. ET. Access details include phone numbers 888-317-6003 (domestic) and 412-317-6061 (international) with passcode 9032041, plus a live webcast on www.vno.com.
07-22 14:31
